Video

Are we Ready to De-escalate Treatment of HPV+ Head & Neck Cancer?

Name: Are we Ready to De-escalate Treatment of HPV+ Head & Neck Cancer?
Uploaded: 2020-01-28T00:00:00+00:00
Description: Changing paradigms for treating HPV+ head & neck cancer

Overview

Dr. Misiukiewicz discusses biologic principles of HPV+ head & neck cancer, changing paradigms, new therapies including immunotherapy and vaccine treatments, and options for reducing severe late toxicity.

Published

January 28, 2020

Created by

Featured Faculty

Krzysztof Misiukiewicz, MD

Associate Professor of Medicine (Hematology and Medical Oncology)
Assistant Professor of Otolaryngology
Icahn School of Medicine at Mount Sinai

View full profile

Related Videos

Video

Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) featuring Munir Ghesani, MD, and Edward Wolin, MD

Learn more about advances in Nuclear Medicine and hear the amazing story of a patient treated at Mount Sinai’s Tisch Cancer Center.

Video

Mount Sinai Acute GVHD International Consortium (MAGIC)

The Mount Sinai Acute GVHD International Consortium comprising 25 BMT centers uses pioneering proteomic techniques to identify and validate biomarkers for skin, gut, and steroid-resistant GVHD.

Video

A Myeloma Carol: The Story of the Past, Present and Future of Myeloma, a Grands Rounds presentation from the Mount Sinai Tisch Cancer Institute

Tremendous progress has been made in improved survival and quality of life for multiple myeloma patients. Continued advancements in effective treatment options has changed the outlook for patients and physicians.

Video

Ropeginterferon (BESREMI) for Polycytheia Vera

John Mascarenhas, MD, discusses findings from the ECLIPSE study.

Video

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure for Myerlofibrosis: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

Improvement in spleen and symptom burden with fedratinib therapy for patients with myelofibrosis

Video

PD-L1 Expression: Practical Implications in Lung Cancer

Tapping into the predictive capability of PD-L1 expression in Non-Small Cell Lung Cancer

Video

Pursuing Progress, Precision, and Equity in Cancer Care

With a particular focus on breast cancer, Dr. Sparano presents on progress in reducing mortality, advancing precision medicine for improved outcomes, and addressing disparities in care and outcomes.